These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human cytomegalovirus (CMV) UL97 D605E mutation has a higher prevalence in infants with primary CMV infection compared with transplant recipients with CMV recurrence. Sun J; Cao G; Zhang L; Zhang Y; Zhao Z; Hu J; Ji Y Transplant Proc; 2012 Dec; 44(10):3022-5. PubMed ID: 23195018 [TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients. Kim YJ; Boeckh M; Cook L; Stempel H; Jerome KR; Boucek R; Burroughs L; Englund JA Transpl Infect Dis; 2012 Dec; 14(6):611-7. PubMed ID: 23198963 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748 [TBL] [Abstract][Full Text] [Related]
6. [Investigation of Ganciclovir Resistance in Cytomegalovirus Strains Obtained from Immunocompromised Patients]. Coşkun A; Gökahmetoğlu S; Özmen P; Çevik Ş; Karakükçü M; Kaynar L; Midilli K; Kuşkucu MA Mikrobiyol Bul; 2020 Oct; 54(4):619-628. PubMed ID: 33107291 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand. Bruminhent J; Rotjanapan P; Watcharananan SP Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524 [TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients. Tasoujlu M; Khalafkhany D; Makhdoomi K; Motazakker M Bratisl Lek Listy; 2022; 123(7):518-522. PubMed ID: 35907059 [TBL] [Abstract][Full Text] [Related]
9. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene. Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247 [TBL] [Abstract][Full Text] [Related]
10. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay. Eckle T; Jahn G; Hamprecht K J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754 [TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load. Sohrabi M; Behzadian F; Hosseini SM; Lashini H Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434 [TBL] [Abstract][Full Text] [Related]
12. Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Jung JY; Nho D; Cho SY; Lee DG; Choi SM; Kim HJ; Kim M; Oh EJ J Infect Chemother; 2022 Oct; 28(10):1415-1418. PubMed ID: 35810104 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance. Recio V; González I; Tarragó D Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation. Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740 [TBL] [Abstract][Full Text] [Related]
16. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient. García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746 [TBL] [Abstract][Full Text] [Related]
17. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir. Abraham B; Lastere S; Reynes J; Bibollet-Ruche F; Vidal N; Segondy M J Clin Virol; 1999 Aug; 13(3):141-8. PubMed ID: 10443790 [TBL] [Abstract][Full Text] [Related]
18. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis. Martin M; Goyette N; Ives J; Boivin G J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805 [TBL] [Abstract][Full Text] [Related]
19. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir. Zhou L; Harder TC; Ullmann U; Rautenberg P J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]